Corbus Pharmaceuticals Holdings, Inc. Annual Operating Income (Loss) in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Corbus Pharmaceuticals Holdings, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2013 to 2023.
  • Corbus Pharmaceuticals Holdings, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$15.5M, a 63.4% decline year-over-year.
  • Corbus Pharmaceuticals Holdings, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$46.2M, a 0.98% decline year-over-year.
  • Corbus Pharmaceuticals Holdings, Inc. annual Operating Income (Loss) for 2023 was -$45.1M, a 13.2% decline from 2022.
  • Corbus Pharmaceuticals Holdings, Inc. annual Operating Income (Loss) for 2022 was -$39.8M, a 28.9% increase from 2021.
  • Corbus Pharmaceuticals Holdings, Inc. annual Operating Income (Loss) for 2021 was -$56M, a 54.4% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$45.1M -$5.24M -13.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-12
2022 -$39.8M +$16.2M +28.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-12
2021 -$56M +$66.8M +54.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-07
2020 -$123M -$45.7M -59.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-08
2019 -$77.1M -$20.4M -35.9% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-15
2018 -$56.7M -$24.2M -74.3% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
2017 -$32.6M -$12.6M -62.9% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-12
2016 -$20M -$11.1M -126% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-12
2015 -$8.85M -$6.21M -234% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-12
2014 -$2.65M -$2.09M -375% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-28
2013 -$557K Jan 1, 2013 Dec 31, 2013 10-K 2015-02-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.